Epidemics III

What you will learn

• Disease Surveillance
• Non-pharmaceutical intervention (NPI)
• Vaccination (Effectiveness, Trials, Safety, Impact on Populations, Vaccine Economics, Confidence and Hesitancy)
• Panel Discussion on WHO?s Response to the Ebola Outbreak
• and Anti-vaccination
• ????
• ?????
• ?? (??, ??, ???, ??????, ?????, ?????)
• ??????: ??????????????????????
• Emerging Infections and Outbreak Detection
• Syndromic Surveillance
• Serologic Surveillance
• Non-pharmaceutical interventions
• Control of Cholera
• Hygiene and Other Personal Interventions
• Isolation and Quarantine and Contact Tracing
• School Closure
• International Measures Including Travel Restrictions and Entry Screening
• Zoonoses – Market Closure
• How Vaccines Work
• Herd Immunity and Other Indirect Benefit
• How to Measure Vaccine Effect
• Vaccine Trials and Safety
• Measuring Vaccine Impact on Populations
• Vaccine Economics
• Vaccine Confidence and Hesitancy
• ??????????
• ????
• ?????
• ?????
• ??????
• ???????????
• ??????????
• ????
• ????, ???????????
• ?????-????
• ????????
• ???????????
• ????????
• ????????
• ??????????
• ?????
• ?????????
• Disease Surveillance Overview
• Emerging Infections and Outbreak Detection
• Syndromic Surveillance
• Serologic Surveillance
• Surveillance – Evaluation of Control Measures (Control Studies)
• Surveillance – Evaluation of Control Measures (Active and Passive Surveillance)
• Surveillance – Evaluation of Control Measures (Vaccine Effectiveness)
• Supplementary Module: Harnessing Multinational Data Sources in Global Models to Inform Vaccine Policy
• Non-pharmaceutical Interventions Overview and John Snow
• Control of Cholera
• Hygiene and Other Personal Interventions
• Isolation and Quarantine and Contact Tracing
• School Closure
• International Measures Including Travel Restrictions and Entry Screening
• Zoonoses – Market Closure
• The Stocking Report
• Outbreak Alert and Emergency Response
• WHO Preparedness Centres
• Ebola Vaccine
• Health System Infrastructure
• Lessons Learned
• Communication Strategy
• Brief History and Current Issues
• How Vaccines Work
• Herd Immunity and Other Indirect Benefit
• How to Measure Vaccine Effect
• Vaccine Trials
• Safety
• Influenza Vaccines
• Measuring Vaccine Impact on Populations
• Vaccine Economics
• Introducing a New Vaccine
• The State of Vaccine Confidence
• Vaccine Confidence and Hesitancy
• Trust
• Measles Vaccine
• Experimental Vaccines: Ebola
• Vaccination: a basic health right?
• Supplementary Module: Digital Health & Epidemiology

Program Overview

?If history is our guide, we can assume that the battle between the intellect and will of the human species and the extraordinary adaptability of microbes will be never-ending.? (1)

Despite all the remarkable technological breakthroughs that we have made over the past few decades, the threat from infectious diseases has significantly accelerated. In this course, we will learn why this is the case by looking at the fundamental scientific principles underlying epidemics and the public health actions behind their prevention and control in the 21st century.

This is the third (control of infectious diseases) of the four courses, covers these topics:

Disease Surveillance

Non-pharmaceutical intervention (NPI)

Vaccination (Effectiveness, Trials, Safety, Impact on Populations, Vaccine Economics, Confidence and Hesitancy)

Panel Discussion on WHO?s Response to the Ebola Outbreak; and Anti-vaccination

??????????????????????????????????????????????????(1)

???????????????????????????????????????????????????????????????????????????????????????????

???????????????????, ???????

????

?????

?? (??, ??, ???, ??????, ?????, ?????)

??????: ??????????????????????

—————————————————————————————————————————————-

(1) Fauci AS, Touchette NA, Folkers GK. Emerging Infectious Diseases: a 10-Year Perspective from the National Institute of Allergy and Infectious Diseases. Emerg Infect Dis 2005 Apr; 11(4):519-25.